Search API
According to the Florida Department of Health (DOH), Arbovirus Surveillance Report, Week 46, travelers from Cuba have been diagnosed with various diseases in 2025.
As of November 15, 2025, the DOH reported 73 travel-related cases of chikungunya have been confirmed in Florida this year, with 62 related to Cuba.
In 2025, 355 cases of dengue fever were reported among individuals who had traveled internationally, with 252 cases among travelers from Cuba.
And one Oropouche case was reported in a traveler from Cuba in November.
According to the U.S. CDC, check the vaccines and medicines list and visit your healthcare provider at least a month before your trip to Cuba in 2025. Various travel vaccines are offered at clinics and pharmacies throughout the United States.

The U.S. Embassy in Kingston, Jamaica, recently issued an alert stating that Hurricane Melissa caused significant damage to the city of Montego Bay. Hurricane Melissa made landfall on October 28, 2025, causing widespread damage.
The Black River community was also heavily damaged.
As of November 14, 2025, the building that houses the U.S. Consular Agency in Montego Bay, Jamaica, sustained storm damage and power outages, and is closed until the building and office are determined to be safe for public access and utilities have been restored.
However, the U.S. Embassy in Kingston, Jamaica's capital city, and the U.S. Consular Agency in The Cayman Islands are open for routine and emergency consular services for U.S. citizens.
The current Level 3 Travel Advisory recommends considering rescheduling planned travel to Jamaica. If you plan to travel, confirm availability with your transportation provider and at your destination before you leave.
From a health perspective, the U.S. CDC writes that Healthcare professionals should ensure international travelers are up to date on travel vaccines and medications, as well as prepared to manage their health before visiting Jamaica.
And local media reported in November 2025 that various cities are offering free vaccine clinics providing free vaccines for flu, COVID, and routine childhood vaccines, accessible from local pharmacies.

The Global Polio Eradication Initiative (GPEI) today reported vaccine-derived poliovirus type 2 (VDPV2) has been detected in an environmental sewage sample collected in Yorkshire and the Humber, in northern England, home to about 5.6 million people.
As of September 16, 2025, the GPEi confirmed that this is the second VDPV2-positive environmental sample reported in the United Kingdom in 2025.
The GPEI says VDPV2 is a strain related to the weakened live poliovirus contained in the oral polio vaccine. If allowed to circulate in under- or unimmunized populations for long enough, or replicate in an immunodeficient individual, the weakened virus can revert to a form that causes illness and paralysis.
The U.S. CDC's Global Polio Travel Health Notice says that Most people with polio do not feel sick. Some people have only minor symptoms, such as fever, tiredness, nausea, headache, nasal congestion, sore throat, cough, stiffness in the neck and back, and pain in the arms and legs. In rare cases, polio infection causes permanent loss of muscle function.
The CDC did include the UK among the 39 countries identified in this Level 2 travel alert.
As of November 18, 2025, the CDC recommends that before traveling to any destination listed, adults who previously completed the complete, routine polio vaccine series may receive a single, lifetime booster dose of polio vaccine.
In the USA, the IPV vaccine is offered at clinics and travel pharmacies.

In a press briefing today, Ethiopia's Health Minister, Dr. Mekdes Daba, said 17 suspected cases of Marburg had been identified and tested during a recent outbreak of the severe disease.
According to a Facebook post on November 17, 2025, Dr. Mekdes noted that six people who exhibited symptoms have died in Ethiopia. However, laboratory confirmation was possible only for the three verified cases.
Dr. Mekdes added, "At this time, there are no individuals in treatment facilities infected with the virus."
However, the minister noted that laboratory tests are still being conducted on those showing symptoms. We continue to collect and process samples, and families of the suspected cases are being informed as the process continues.
Since its initial outbreak in 1967 in Germany, Marburg virus disease has been reported in various countries.
The U.S. CDC says watch your health for symptoms of Marburg while in the outbreak area and for 21 days after leaving. If you develop symptoms, separate yourself from others immediately and do not travel.
Currently, no vaccines for Marburg disease are available.
Note: This Vax-Before-Travel.com news article was updated on November 18, 2025.

Based on internal Wallgreens pharmacy data, the Respiratory Illness Index map shows minimal influenza reports for the 2025-2026 respiratory season.
Seperately, the U.S. CDC Influenza Surveillance Report: Key Updates for Week 45, ending November 8, 2025, says seasonal influenza activity remains low nationally but is increasing in some areas.
On November 14, 2025, the CC wrote that the percent positivity for influenza and the percentage of emergency department visits for influenza among pediatric age groups increased last week. And the timing of the increasing activity is similar to several past seasons, including the 2024-2025 season.
The best news from the CDC is that no influenza-associated pediatric deaths occurring during the 2025-2026 season have been reported to the CDC.
The CDC recommends that everyone ages 6 months and older get an annual influenza vaccine anytime viruses are circulating.
From an access perspective, more than 121 million doses of influenza vaccine have been distributed in the United States this season, and are readily available at local pharmacies.

Recent data shows that of the 10.7 million tuberculosis (TB) cases reported last year, the highest number was in the South-East Asia region.
According to the World Health Organization (WHO) global TB report published on November 12, 2025, India ranks ahead of Indonesia, the Philippines, China, and Pakistan in TB cases.
The positive news from the WHO is that India has achieved a significant TB milestone, recording a 21% decrease in TB incidence.
Since TB is a vaccine-preventable disease, and India has access to an ample supply, Bacille Calmette-Guérin (BCG) vaccination campaigns are scheduled to continue in 2026.
As of November 16, 2025, the U.S. CDC does not recommend BCG vaccination before visiting India.

Marburg virus disease has been detected in the South Ethiopia Region, the first of its kind in the country, following laboratory testing of samples from a cluster of suspected cases of viral haemorrhagic fever.
As of November 14, 2025, the World Health Organization (WHO) has reported a total of 9 cases in the outbreak affecting Jinka town in the South Ethiopia Region.
In the African region, previous Marburg outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of the Congo, Ghana, Kenya, Equatorial Guinea, Rwanda, South Africa, Tanzania, and Uganda.
Marburg's initial outbreak was detected in Germany in 1967.
Marburg is a severe and often fatal illness transmitted to humans from fruit bats and spreads among people through direct contact with the bodily fluids of infected individuals or contaminated materials.
The WHO and national authorities are scaling up the response, including community-wide screening, case isolation, treatment, contact tracing, and public awareness campaigns to curb the spread of the Marburg virus, which belongs to the same family of viruses as Ebola virus disease.
Currently, no approved Marburg vaccines are available.
However, in April 2025, the Albert B. Sabin Vaccine Institute recently launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, based on the cAd3 platform.
Currently, about five other Marburg vaccine candidates are being tested in clinical research.
Updated on November 17, 2025 - Organisations undertaking business in Ebola or Marburg-affected areas should register with the UK Health Security Agency returning workers scheme.

The World Health Organization (WHO today announced that in the Democratic Republic of the Congo (DRC), the first signs of the Ebola virus were detected in a maternity ward in Bulape, located in the Kasai Province.
A pregnant woman arrived showing unusual symptoms of this severe disease. The midwife on duty at the time assisted the woman through labour.
While handling the needle used on the patient, she accidentally pricked herself. A few days later, the midwife passed away, along with the mother and newborn.
Antho, the head of the maternity ward, was also present, commented in a WHO press release on November 14, 2025, "Not only was I wearing gloves, but each time I touched the patient, I went out and washed my hands with soap and water."
"It was hard to lose Juliette (midwife). We'd worked together for a long time, and even in the toughest moments, she supported the team. Her loss has left a big void."
The ongoing Ebola response in the DRC has focused on strengthening infection prevention along with other key outbreak control measures. This area has previously reported several Ebola outbreaks.
In public health emergencies, the WHO says infection prevention and control are pivotal in saving lives.
Currently, the DRC has access to Ebola vaccines and antibody treatments.
